Overview

A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This study will determine the efficacy of clofarabine as measured by response rate in patients with aggressive non-Hodgkin's lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
Kristie Blum
Ohio State University Comprehensive Cancer Center
Treatments:
Clofarabine